Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M192,367Revenue (TTM) $M53,244Net Margin (%)11.6Altman Z-Score2.0
Enterprise Value $M222,385EPS (TTM) $1.0Operating Margin %23.5Piotroski F-Score5
P/E(ttm)31.7Beneish M-Score-2.5Pre-tax Margin (%)13.6Higher ROA y-yN
Price/Book3.010-y EBITDA Growth Rate %2.6Quick Ratio0.9Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %1.2Current Ratio1.1Lower Leverage y-yN
Price/Free Cash Flow15.4y-y EBITDA Growth Rate %-17.6ROA % (ttm)3.6Higher Current Ratio y-yN
Dividend Yield %3.8PEG25.8ROE % (ttm)9.6Less Shares Outstanding y-yY
Payout Ratio %118Shares Outstanding M6,068ROIC % (ttm)11.7Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEKahn Brothers 2016-09-30 Reduce-1.62%$33.32 - $37.31
($35.24)
$ 31.70-10%Reduce -20.50%919,757
PFEJoel Greenblatt 2016-09-30 Reduce-0.33%$33.32 - $37.31
($35.24)
$ 31.70-10%Reduce -40.21%1,158,937
PFENWQ Managers 2016-09-30 Add0.13%$33.32 - $37.31
($35.24)
$ 31.70-10%Add 12.67%2,360,862
PFECharles Brandes 2016-09-30 Reduce-0.11%$33.32 - $37.31
($35.24)
$ 31.70-10%Reduce -3.81%5,032,007
PFEJohn Paulson 2016-09-30 Reduce-0.1%$33.32 - $37.31
($35.24)
$ 31.70-10%Reduce -50.63%252,000
PFEBarrow, Hanley, Mewhinney & Strauss 2016-09-30 Reduce-0.09%$33.32 - $37.31
($35.24)
$ 31.70-10%Reduce -3.50%47,267,043
PFERichard Pzena 2016-09-30 Add0.03%$33.32 - $37.31
($35.24)
$ 31.70-10%Add 6.55%2,329,636
PFET Rowe Price Equity Income Fund 2016-09-30 Reduce-0.01%$33.32 - $37.31
($35.24)
$ 31.70-10%Reduce -0.48%13,875,000
PFEKeeley Asset Management Corp 2016-09-30 Reduce-0.01%$33.32 - $37.31
($35.24)
$ 31.70-10%Reduce -8.92%91,630
PFEKen Fisher 2016-09-30 Add0.01%$33.32 - $37.31
($35.24)
$ 31.70-10%Add 0.35%31,836,368
PFERonald Muhlenkamp 2016-09-30 Reduce-0.01%$33.32 - $37.31
($35.24)
$ 31.70-10%Reduce -2.74%36,034
PFEFirst Eagle Investment 2016-09-30 Reduce$33.32 - $37.31
($35.24)
$ 31.70-10%Reduce -13.15%66,061
PFERuane Cunniff 2016-09-30 Sold Out $33.32 - $37.31
($35.24)
$ 31.70-10%Sold Out0
PFEMario Gabelli 2016-09-30 Reduce$33.32 - $37.31
($35.24)
$ 31.70-10%Reduce -3.00%502,386
PFEDodge & Cox 2016-09-30 Reduce$33.32 - $37.31
($35.24)
$ 31.70-10%Reduce -6.92%773,142
PFEKahn Brothers 2016-06-30 Reduce-1.59%$29.64 - $35.31
($33.58)
$ 31.70-6%Reduce -19.80%1,156,866
PFEDavid Tepper 2016-06-30 Sold Out -1.32%$29.64 - $35.31
($33.58)
$ 31.70-6%Sold Out0
PFEDavid Dreman 2016-06-30 Add0.52%$29.64 - $35.31
($33.58)
$ 31.70-6%Add 414.81%29,962
PFEVanguard Health Care Fund 2016-06-30 Sold Out -0.48%$29.64 - $35.31
($33.58)
$ 31.70-6%Sold Out0
PFEBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Reduce-0.21%$29.64 - $35.31
($33.58)
$ 31.70-6%Reduce -8.83%48,981,192
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MADDALUNA ANTHONY JExecutive Vice President 2016-11-09Sell10,000$33-3.94view
BOURLA ALBERTGroup President 2016-11-04Sell18,390$30.055.49view
DAMELIO FRANK AExecutive Vice President 2016-05-26Sell100,000$34.49-8.09view
CANGIALOSI LORETTA VSr. Vice President, Controller 2016-05-24Sell86,000$33.97-6.68view
OLSON LAURIE JExecutive Vice President 2016-05-11Sell4,700$33.5-5.37view
YOUNG JOHN DGroup President 2016-05-10Sell41,700$33.53-5.46view
DAMELIO FRANK AExecutive Vice President 2016-05-10Sell192,000$33.66-5.82view
READ IAN CChairman & CEO 2016-05-09Sell275,000$33.8-6.21view
SUSMAN SALLYExecutive Vice President 2016-05-09Sell67,884$33.71-5.96view
HILL CHARLES HExecutive Vice President 2016-05-09Sell29,600$33.84-6.32view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    US Market Indexes End the Week Higher Dec 09 2016 
    Robust Pipeline Supports 5.5% Dividend Yield Dec 05 2016 
    US Market Indexes Higher on Tuesday Nov 29 2016 
    Small-Cap Biotech Is on Front Lines of Fight Against Depression Nov 22 2016 
    How a 15% Decline Is a Gift to Income Investors Nov 21 2016 
    3 Health Industry Sectors Bound to Profit From a Trump Presidency Nov 11 2016 
    Johnson & Johnson Expect it to Deliver Consistent Results Nov 08 2016 
    Allergan: Trading at a Low Earnings Multiple Nov 06 2016 
    US Market Indexes Lower on Tuesday Nov 02 2016 
    Seven New Stocks in My Purloined Portfolio Oct 19 2016 

    More From Other Websites
    US Market Indexes End the Week Higher Dec 09 2016
    Markets Right Now: Stocks extend rally to new highs Dec 09 2016
    Stocks poised for records as S&P 500 on pace for longest streak since 2014 Dec 09 2016
    Stock Market Indexes Rally To New Highs; Apple, Microsoft Boost Dow Dec 09 2016
    Pfizer Up Along with Other Healthcare Stocks Dec 09 2016
    Pfizer’s Eighth Consecutive Quarter of Revenue Growth Dec 09 2016
    Understanding Pfizer’s 3Q16 Performance Dec 09 2016
    Stocks Up Again; Apple Strengthens, Reclaims 50-Day Line Dec 09 2016
    11:30 am Pfizer and Akili Interactive Labs present 'positive' topline data showing that Akili's... Dec 09 2016
    Listing the Reasons behind Pfizer’s Discounted Price-to-Earnings Dec 09 2016
    Pharma Stock Roundup: Drug Pricing Heat Back on Sector, Endo, Mylan, AZN to Cut Jobs Dec 09 2016
    Pfizer May Be Setting Up as a Low-Risk Buy Dec 09 2016
    Health care sector suffers: Time to buy the dip? Dec 08 2016
    Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK Dec 08 2016
    Patients' Right To Try Should Not Be A License To Fleece Them Dec 08 2016
    Blog Coverage Pfizer Fined $107 Million for Overcharging Through an Antiepileptic Drug Dec 08 2016
    Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug Dec 08 2016
    Asian stocks advance ahead of ECB decision Dec 07 2016
    Business Highlights Dec 07 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)